Plus: Novartis acquires Avidity Biosciences in a $12 billion deal. And Australia's consumer watchdog accuses Microsoft of misleading customers on AI pricing. Zoe Kuhlkin hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices

my private podcast channel
Plus: Novartis acquires Avidity Biosciences in a $12 billion deal. And Australia's consumer watchdog accuses Microsoft of misleading customers on AI pricing. Zoe Kuhlkin hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices